TONIGHT! Join in as Kyle Dennis, 27 year-old,
self-made millionaire, reveals his newest trading strategy.
self-made millionaire, reveals his newest trading strategy.
Days
Hours
Minutes
Seconds
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -1.14% | 78.63 | 1.2% | $618.81m | |
| AMGN | Amgen Inc. | 0.16% | 178.24 | 1.2% | $557.24m | |
| GILD | Gilead Sciences, Inc. | -0.22% | 67.38 | 0.9% | $542.96m | |
| BIIB | Biogen Inc. | 0.63% | 286.21 | 1.2% | $478.24m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.30% | 293.74 | 2.6% | $304.78m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.34% | 157.50 | 1.9% | $219.69m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.51% | 117.74 | 2.0% | $210.05m | |
| ILMN | Illumina, Inc. | -1.70% | 266.22 | 3.5% | $198.41m | |
| A | Agilent Technologies, Inc. | -1.50% | 63.16 | 1.5% | $196.40m | |
| NKTR | Nektar Therapeutics | -0.77% | 79.96 | 6.0% | $184.19m | |
| INCY | Incyte Corporation | 2.64% | 68.43 | 2.5% | $149.75m | |
| BMRN | BioMarin Pharmaceutical Inc. | 4.77% | 92.49 | 4.4% | $135.47m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.85% | 91.65 | 16.6% | $126.22m | |
| BLUE | Bluebird Bio, Inc. | 0.62% | 188.15 | 15.7% | $98.65m | |
| EXAS | Exact Sciences Corporation | -1.95% | 51.82 | 25.5% | $98.64m |
Company Profile
Esperion Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). It offers Bempedoic acid and Ezetime combination pill as therapies that have been shown to lower elevated LDL-C levels in patients with hypercholesterolemia, including patients inadequately treated with current lipid-modifying therapies. The company was founded by Roger S. Newton and Charles L. Bisgaier on January 22, 2008 and is headquartered in Ann Arbor, MI.